Patent Assignment
Reel/Frame 055969/0628
Assignment of Assignor's Interest
Recorded: 2021-04-20
Pages: 10
Assignors
SIDDIQUI-JAIN, ADAM
Executed: 2019-12-18
FLYNN, PAUL
Executed: 2019-12-10
FUJIWARA, YUJI
Executed: 2019-12-18
Assignee
TOLERO PHARMACEUTICALS, INC.
3900 N. TRAVERSE MOUNTAIN BLVD., LEHI, UTAH, 84043
Covered Property
(1)
CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 20, 2021
From: MASUMOTO, SHUJI; TANAKA, HIROAKI; KUREBAYASHI, HIROTAKA; HASHIZUKA, TAKAHIKO
To: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
Reel/Frame 055970/0232 →
Assignment of Assignor's Interest
Apr 20, 2021
From: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 055970/0580 →
Merger
Apr 20, 2021
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 055970/0691 →
Change of Name
Apr 20, 2021
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 056065/0276 →
Change of Name
Apr 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059809/0557 →